Envista (NVST) to Release Quarterly Earnings on Wednesday

Envista (NYSE:NVST – Get Free Report) is anticipated to announce its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.3350 per share and revenue of $716.0880 million for the quarter. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Individuals can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.

Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. The business had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.03 million. Envista had a return on equity of 7.11% and a net margin of 2.41%.The business’s revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.24 earnings per share. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Get Envista alerts:

Envista Stock Performance

NYSE NVST opened at $27.39 on Monday. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. Envista has a twelve month low of $18.77 and a twelve month high of $30.42. The business has a 50-day moving average price of $25.59 and a 200-day moving average price of $25.91. The firm has a market cap of $4.46 billion, a price-to-earnings ratio of 66.80, a price-to-earnings-growth ratio of 1.55 and a beta of 0.86.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on NVST shares. Morgan Stanley upped their price target on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, April 24th. Weiss Ratings downgraded shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Evercore restated an “outperform” rating and set a $33.00 target price on shares of Envista in a research report on Thursday, May 7th. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, BMO Capital Markets initiated coverage on shares of Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target on the stock. Six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, Envista has an average rating of “Hold” and an average price target of $28.62.

Read Our Latest Analysis on Envista

Institutional Trading of Envista

Hedge funds have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd grew its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Envista by 46.1% in the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares during the last quarter. Finally, Quarry LP bought a new stake in shares of Envista in the 3rd quarter worth about $66,000.

Envista Company Profile

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Read More

• Five stocks we like better than Envista
• 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
• AbbVie Quietly Solved Its Biggest Problem—Now What?
• Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
• Strategy’s Structural Strength: Hidden in a $8 Billion Illusion

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.